2015
DOI: 10.1016/j.copbio.2014.11.004
|View full text |Cite
|
Sign up to set email alerts
|

Knowledge-driven approaches for engineering complex metabolic pathways in plants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
4

Relationship

1
9

Authors

Journals

citations
Cited by 45 publications
(17 citation statements)
references
References 58 publications
0
17
0
Order By: Relevance
“…The impact of metabolic engineering and molecular farming in the pharmaceutical industry is going to increase with the introduction of innovative methods throughout the development chain, from discovery [53] through to the introduction of precise genome modifications and targeted interventions using the latest genome editing tools based on the CRISPR/Cas9 system [54], the integration of quality in the design process to develop optimized production processes that can be scaled up to process scale without loss of yield or quality, and the implementation of the latest regulatory guidelines to ensure that processes are robust, reproducible, safe and efficient to encourage regulatory approval. This study showed that BY-2 cells can be cultivated in disposable bioreactors that are more versatile than conventional bioreactors, and cell growth and the yield of a recombinant antibody (20 mg/l) were comparable to standard shake flask cultivation despite the 200-fold increase in scale.…”
Section: Conclusion and Future Prospectsmentioning
confidence: 99%
“…The impact of metabolic engineering and molecular farming in the pharmaceutical industry is going to increase with the introduction of innovative methods throughout the development chain, from discovery [53] through to the introduction of precise genome modifications and targeted interventions using the latest genome editing tools based on the CRISPR/Cas9 system [54], the integration of quality in the design process to develop optimized production processes that can be scaled up to process scale without loss of yield or quality, and the implementation of the latest regulatory guidelines to ensure that processes are robust, reproducible, safe and efficient to encourage regulatory approval. This study showed that BY-2 cells can be cultivated in disposable bioreactors that are more versatile than conventional bioreactors, and cell growth and the yield of a recombinant antibody (20 mg/l) were comparable to standard shake flask cultivation despite the 200-fold increase in scale.…”
Section: Conclusion and Future Prospectsmentioning
confidence: 99%
“…A number of recent reviews have focused on the engineering of complex metabolic pathways in plant hosts. 13,14 In this section, we focus on strategies and Benjamin J. Kotopka obtained a Bachelor's degree in molecular biology from Princeton University in 2013. He is currently a PhD student in Prof. Christina Smolke's group at Stanford University.…”
Section: Heterologous Phytochemical Production In Plant Systemsmentioning
confidence: 99%
“…Although here we focus primarily on the engineering of plant parts drawn from signalling and cell biology, there is significant research activity in synthetic metabolic engineering 6,7 , with many recent headlines stemming from successful porting of opiate 8 and cannabinoid 9 production into yeast.…”
Section: Identification and Remediation Of Toxinsmentioning
confidence: 99%